Abstract:Neurovascular dysfunction, as an integral part of Alzheimer's disease, may have an important influence on the onset and progression of chronic neurodegenerative processes. The blood-brain barrier (BBB) pathway is one of the main pathways that mediates the clearance of amyloid-beta (Aβ) in the brain parenchyma. A large number of studies have shown that receptors and ATP-binding cassette transporters expressed on endothelial cells play an important role in Aβ transport across the BBB, but the specific mechanism is not clear. In this review, we summarize the possible mechanisms of Aβ production and clearance, and in particular the relationship between Aβ and brain capillary endothelial cells. Aβ is produced by abnormal cleavage of the amyloid precursor protein via amyloidogenic processing under pathological conditions. Dysregulation of Aβ clearance is considered to be the main reason for the massive accumulation of Aβ in the brain parenchyma. Several pathways mediating Aβ clearance from the brain into the periphery have been identified, including the BBB pathway, the blood-cerebrospinal fluid barrier and arachnoid granule pathway, and the lymphoid-related pathway. Brain capillary endothelial cells are the key components of Aβ clearance mediated by BBB. Receptors (such as LRP1, RAGE, and FcRn) and ATP-binding cassette transporters (such as P-gp, ABCA1, and ABCC1) expressed on endothelial cells play a critical role in Aβ transcytosis across the BBB. The toxic effects of Aβ can induce dysregulation of receptor and transporter expression on endothelial cells. Excessive Aβ exerts potent detrimental cerebrovascular effects by promoting oxidative stress, inducing chronic inflammation, and impairing endothelial structure and functions. All of these are main causes for the reduction in Aβ clearance across the BBB and the accumulation of Aβ in the brain parenchyma. Therefore, studies on the interactions between Aβ and brain capillary endothelial cells, including their receptors and transporters, studies on inhibition of the toxic effects of Aβ on endothelial cells, and studies on promoting the ability of endothelial cells to mediate Aβ clearance may provide new therapeutic strategies for Aβ clearance in Alzheimer's disease.

Amyloid-β-interacting proteins in peripheral fluids of Alzheimer’s disease

Progress in molecular mechanisms of β-amyloid peptides in alzheimer's disease

Pathology of Amyloid-β (Aβ) Peptide Peripheral Clearance in Alzheimer's Disease

Peripheral blood amyloid-β involved in the pathogenesis of Alzheimer's disease via impacting on peripheral innate immune cells

Clearance of Amyloid Beta and Tau in Alzheimer’s Disease: from Mechanisms to Therapy

Advances in Amyloid-β Clearance in the Brain and Periphery: Implications for Neurodegenerative Diseases

Clearance and transport of amyloid β by peripheral monocytes correlate with Alzheimer's disease progression

The Release and Transmission of Amyloid Precursor Protein Via Exosomes

The relationship between amyloid-beta and brain capillary endothelial cells in Alzheimer’s disease

Physiological β-amyloid clearance by the liver and its therapeutic potential for Alzheimer's disease

Interactions between Beta-Amyloid and Pericytes in Alzheimer's Disease

Endothelial leakiness elicited by amyloid protein aggregation

The Amyloid-Beta Clearance: From Molecular Targets to Glial and Neural Cells

Microglia receptors and their implications in the response to amyloid β for Alzheimer’s disease pathogenesis

Proteomic Analysis Reveals Physiological Activities of Aβ Peptide for Alzheimer's Disease

The Role of Intracellular Amyloid Beta in Alzheimer'S Disease

Suppression of glymphatic fluid transport in a mouse model of Alzheimer's disease.

Approaches for Increasing Cerebral Efflux of Amyloid-β in Experimental Systems

Specific Binding of Alzheimer's Aβ Peptides to Extracellular Vesicles

Intracellular A beta and its Pathological Role in Alzheimer's Disease: Lessons from the Cellular to Animal Model

Involvement of the glymphatic/meningeal lymphatic system in Alzheimer's disease: insights into proteostasis and future directions